Colistin is relevant in the treatment of infections caused by multidrug-resistant microorganisms; however, it is not exempt from adverse renal events such as acute kidney injury (AKI), acute tubular dysfunction (ATD) and electrolyte imbalances, the latter two being little described in the literature. Therefore, the present study aimed to describe and analyze the electrolyte and urinary excretion disorders associated with the prescription of colistin, as well as the associated renal outcomes.
No takes yet. Share an insight, caveat, or question.
Estrella et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: